A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy

A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy
Condition:   Melanoma
Interventions:   Biological: Tetanus Diptheria Vaccine;   Biological: Polio Boost Immunization
Sponsor:   Duke University
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 15, 2021Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments